Increasing the therapeutic efficacy of docetaxel for cutaneous squamous cell carcinoma through the combined inhibition of phosphatidylinositol 3-kinase/AKT signalling and autophagy.

Wright, T J, McKee, C, Birch-Machin, M A, Ellis, R, Armstrong, Jane and Lovat, P E (2013) Increasing the therapeutic efficacy of docetaxel for cutaneous squamous cell carcinoma through the combined inhibition of phosphatidylinositol 3-kinase/AKT signalling and autophagy. Clinical and Experimental Dermatology. ISSN 1365-2230

More Information

Depositing User: Glenda Young

Identifiers

Item ID: 3804

Identification Number: https://doi.org/10.1111/ced.12138

ISSN: 1365-2230

URI: http://sure.sunderland.ac.uk/id/eprint/3804

Official URL: http://onlinelibrary.wiley.com/doi/10.1111/ced.121...

Users with ORCIDS

ORCID for Jane Armstrong: orcid.org/0000-0002-5822-0597

Catalogue record

Date Deposited: 18 Apr 2013 11:08

Last Modified: 18 Dec 2019 15:35

Contributors

Author:	Jane Armstrong
Author:	T J Wright
Author:	C McKee
Author:	M A Birch-Machin
Author:	R Ellis
Author:	P E Lovat

University Divisions

Faculty of Health Sciences and Wellbeing
Faculty of Health Sciences and Wellbeing > School of Pharmacy and Pharmaceutical Sciences
Faculty of Health Sciences and Wellbeing > School of Nursing and Health Sciences

Subjects

Sciences > Pharmacy and Pharmacology

Actions (login required)

View Item (Repository Staff Only)